BIOTRONIK, Inc. Announces The First U.S. Implant Of Lumax 540 Series - A Therapy For Patients Suffering From Heart Failure
BIOTRONIK, Inc., announced the first U.S. implant of the next-generation Lumax 540 Series defibrillator for treating patients with heart failure. The Lumax 540 Series was recently approved by the U.S. Food and Drug Administration (FDA). The Lumax 5 Series represents the latest devices from BIOTRONIK in its full-line of patient-focused Cardiac Rhythm Management (CRM) products engineered for electrophysiologists who demand superior quality and reliability. The first U.S.
More: continued here
Filed under: Cardiovascular on April 16th, 2009
You must be logged in to post a comment.